Delivery Order SPE2DR25D3010-SPE2DR26F88EF
- Not listed
- The Defense Logistics Agency awarded a $6,672.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for Crexont ER 87.5 mg-350 mg capsules (120 count) on September 5, 2025, with completion targeted for September 8, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $3,642.37 delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of Crexont ER 70 MG-280 MG capsules (120-count). The contract is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located at the...
- The Defense Logistics Agency awarded a $1,627.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CREXONT ER 87.5 MG-350 MG capsules (120-count supply) on December 5, 2025, with completion scheduled for December 8, 2025. This non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $5,303.83 to AmerisourceBergen Drug Corp for CREXONT ER 87.5 MG-350 MG capsules (120 count) on December 15, 2025, with completion scheduled for December 16, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the contractor's critical role as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.79 to AmerisourceBergen Drug Corp for Crexont ER 70 mg-280 mg capsules (120 count). This non-set-aside, firm fixed-price delivery order was executed on November 25, 2025, with an ultimate completion date of November 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,255.04 to AmerisourceBergen Drug Corp for Crexont ER 87.5 mg-350 mg capsules (120 count) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed price contract was issued without a set-aside designation and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,231.88 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for CREXONT ER 70 mg-280 mg capsules (120-count supply). This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 28, 2025, and performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,030.34 to AmerisourceBergen Drug Corp for the supply of CREXONT ER 87.5 MG-350 MG capsules (120 count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This delivery order represents a firm fixed price contract with no set-aside designation, issued under open competition. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,379.61 to AmerisourceBergen Drug Corp for CREXONT ER 52.5 MG-210 MG capsules (120-count). This non-set-aside, competitively awarded contract features firm fixed-price terms with an ultimate completion date of November 26, 2025. The prime contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,173.44 to AmerisourceBergen Drug Corp on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. The delivery order will be...
- SPE2DR25D3010Indefinite Delivery Contract
- SPE2DR25D3010-SPE2DR26F88EFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Crexont ER 87.5 mg-350 mg capsules (120 count) with a ceiling value of $3,224.67. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio of federal contracts demonstrates its capability to supply a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order is a child contract under the larger SPE2DX vehicle, which enables AmerisourceBergen to support Department of Defense healthcare programs globally and serve customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 12/7/25 |